Advance your Oligonucleotide Therapeutics towards Commercial Success
With Thanks to the EuroTides 2016 Scientific Advisory Board:
- Troels Koch, VP & Head of Research, RNA Therapeutics, Roche Innovation Center Copenhagen A/S, Denmark
- Thomas Rupp, Owner, Thomas Rupp Consulting, Germany
- Yogesh Sanghvi, President, Rasayan, USA
- Brian Sproat, Managing Director, Chemconsilium, Belgium
- Cy Stein, Department of Medical Oncology and Experimental Therapeutics, City of Hope Medical Center, USA
- Stefan Vonhoff, Vice President CMC, Noxxon Pharma AG, Germany
- Muthiah (Mano) Manoharan, Senior VP, Drug Discovery, Alnylam Pharmaceuticals, Inc, USA
- Mike Gait, MRC Programme Leader, MRC Laboratory of Molecular Biology, UK
EuroTides is an excellent business platform to meet existing and new customers in peptides and oligonucleotides development & manufacturing and at the same time learn about today’s problems and tomorrow needs.
Business Development Director
Was an excellent meeting giving me the chance to hear about new developments and to interact with colleagues in a relaxed atmosphere
Well attended event with attendees from all parts of peptide clinical development. The talks on peptide manufacture and issues that can arise were excellent.
PARTNERING OPPORTUNITIES AT TIDES: EUROPE 2017
Whether you're increasing your company profile, launching a new product or creating business development opportunities we have a package to suit your needs.
We can provide flexible and tailored solutions to optimise your investment. To discuss these or any other opportunities for your business please contact:
T:+44 207 017 7247